Key Takeaways Hologic's Breast Health revenues rose 4.8% to $393.7 million in the fiscal fourth quarter.Growth was driven by interventional products, Endomagnetics sales and Hologic's better U.S. execution.Hologic's$79-per-share takeover by Blackstone and TPG spotlights the division's strategic importance.Hologic (HOLX) exited the fourth quarter of fiscal 2025, achieving a turnaround for its Breast Health division. Revenues increased 4.8% to $393.7 million, mainly driven by strong sales of interventional p ...